MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617075059 A) filed by Voyager Therapeutics, Inc. on June 17, 2026, for Compositions And Methods For The Treatment Of Disorders Related To Frataxin Deficiency.
Inventors include Nonnenmacher, Mathieu Emmanuel; Lin, Jing; Wang, Hongxing; Hou, Jinzhao Number; Wang, Wei; and Li, Jiangyu.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The disclosure relates to compositions and methods for, inter alia, altering, e.g., enhancing, the level of FXN protein via delivery using an adeno-associated viral (AAV) capsid variant. The compositions and methods of the present disclosure are useful, inter alia, for the treatment of subjects who have, have been diagnosed with having, or are at risk of having a disorder associated with frataxin (FXN) deficiency, e.g., Friedreich's Ataxia (FA), or at least one symptom thereof.
Disclaimer: Curated by HT Syndication.
